Related Experiment Video
Updated: Jun 10, 2026
06:38
Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
[Risk assessment of renal dysfunction caused by occupational lead exposure]
Li-ting Tian1, Li-jian Lei, Xiu-li Chang
1School of Public Health, Fudan University, Shanghai 200032, China.
Summary
Occupational lead exposure in battery factory workers significantly increases the risk of kidney dysfunction. This risk is directly related to lead dose, as indicated by blood lead (BPb) and urinary lead (UPb) levels.
Area of Science:
- Occupational Health
- Toxicology
- Epidemiology
Context:
- Lead exposure is a significant occupational hazard, particularly in industries like battery manufacturing.
- Renal dysfunction is a known consequence of heavy metal toxicity.
- Assessing the dose-response relationship is crucial for risk management.
Purpose:
- To investigate the epidemiological link between occupational lead exposure and renal dysfunction.
- To quantify the risk of kidney damage in battery factory workers exposed to lead.
- To establish biomarkers for exposure and effect, and calculate benchmark doses (BMD).
Summary:
- Workers in a battery factory showed significantly elevated blood lead (BPb) and urinary lead (UPb) levels compared to controls.
- Increased levels of urinary N-acetyl-D-glucosaminidase (UNAG) and urinary albumin (UALB) indicated renal dysfunction in the exposed group.
- A significant positive correlation was found between external lead dose and internal biomarkers (BPb, UPb), demonstrating a clear dose-response relationship.
Impact:
- This study confirms that occupational lead exposure causes dose-dependent renal dysfunction.
- The calculated benchmark doses (BMD) for BPb and UPb provide quantitative risk assessment values for renal dysfunction.
- Findings support the need for stringent occupational health and safety measures to mitigate lead-induced kidney damage.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...